Clozapine in the Treatment of Obsessive-compulsive Symptoms in Schizophrenia Patients: A Case Series Study

Introduction: Obsessive-compulsive (OC) symptoms have been observed in a substantial proportion of schizophrenic patients. There are some reports describing the appearance de novo or reemergence of preexisting OC symptoms under clozapine (CLZ) therapy. However, there are also reports describing a positive effect of CLZ therapy in OC schizophrenic patients. It seems that comorbid OC symptoms are common among CLZ-treated refractory schizophrenic patients and are likely to be an integral part of their illness. The complex nature of the treatment response in this group of schizophrenic patients is as yet unclear. The effects of CLZ on OC symptoms may vary, with evidence of improvement in some and worsening among others. Methods: The present case series study describes our experience with CLZ as a sole agent (n = 10) or in combination with serotonin reuptake inhibitors (n = 5), in schizophrenic patients with prominent OC symptomatology. Results: Systematic analysis of clinical features of our patients, as well as findings in the literature to date, led us to suggest some factors that may predict response to CLZ treatment in treatment-resistant schizophrenic patients with prominent OC symptoms: 1) schizophrenic patients who began to exhibit OC symptoms within the course of the psychotic process need and might to be successfully treated with CLZ alone; 2) when OC symptomatology preceded the development of schizophrenic process, CLZ monotherapy is inefficient and may even worsen OC symptoms; therefore, it should be treated concomitantly with specific anti-obsessive agents; 3) in both groups there is a definite dose-related pro-obsessive influence of CLZ when it is given in high doses. Discussion: Further controlled investigations in a larger cohort of OC schizophrenic patients are needed to substantiate our hypothesis.

Abbreviations

OCD:Obsessive-compulsive disorder

OCS:Obsessive-compulsive symptoms

SRI:Serotonin reuptake inhibitors

References

• 1 Allen L, Tejera C. Treatment of clozapine-induced obsessive-compulsive symptoms with sertraline (letter).  Am J Psychiat. 1994;  151 1096-1097
• 2 Baker R W, Ames D, Umbricht D S, Chengappa K N, Schooler N R. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo.  Psychopharmacol Bull. 1996;  32 89-93
• 3 Baker R W, Bermanzohn P C, Wirshing D A, Chengappa K NR. Obsessions, compulsions, clozapine, and risperidone.  CNS Spectrums.. 1997;  2 26-36
• 4 Baker R W, Chengappa K N, Baird J W, Steingard S, Christ M A, Schooler N R. Emergence of obsessive compulsive symptoms during treatment with clozapine.  J Clin Psychiat. 1992;  53 439-442
• 5 Berman I, Chang H H, Klegon D A. Is there a distinct subtype of obsessive-compulsive schizophrenia?.  Psychiatric Ann. 1999;  30 652-649
• 6 Berman I, Merson A, Viegner B, Losonczy M F, Pappas D, Green A I. Obsessions and compulsions as a distinct cluster of symptoms in schizophrenia: a neuropsychological study.  J Nerv Ment Dis. 1998;  186 150-156
• 7 Bermanzohn P C, Porto L, Arlow P, Pollack S, Stronger R, Siris S G. Are some neuroleptic-refractory symptoms in schizophrenia really obsessions?.  CNS Spectrums. 1997;  2 51-57
• 8 Biondi M, Fedele L, Arcangeli T, Pancheri P. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine (letter).  Psychother Psychosom. 1999;  68 111-112
• 9 Bland R C, Newman S C, Orn H. Schizophrenia: lifetime comorbidity in a community sample.  Acta Psychiat Scand. 1987;  75 383-391
• 10 Buckley P F, Sajatovic M, Meltzer H Y. Treatment of delusional disorders with clozapine (letter).  Am J Psychiat. 1994;  151 1394-1395
• 11 Burgy M. Clozapine and obsessive-compulsive symptoms in schizophrenia. A case history of one patient.  Nervenarzt. 1999;  70 64-67
• 12 Cassady S L, Thaker G K. Addition of fluoxetine to clozapine) letter).  Am J Psychiatry. 1992;  149 27
• 13 Centorrino F, Baldessarini R J, Frankenburg F R, Kando J, Volpicelli S A, Flood J G. Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.  Am J Psychiat. 1996;  153 820-822
• 14 Chang H H, Berman I. Treatment issues for patients with schizophrenia who have obsessive-compulsive symptoms. Psychiatric Ann 1999: 529-532
• 15 de Haan L, Linszen D H, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders.  J Clin Psychiat. 1999;  60 364-365
• 16 Eales M J, Layeni A O. Exacerbation of obsessive-compulsive symptoms associated with clozapine) letter).  Br J Psychiat. 1994;  164 687-688
• 17 Fenton W S, McGlashan T H. The prognostic significance of obsessive-compulsive symptoms in schizophreni.  Am J Psychiat. 1986;  143 437-441
• 18 First M B, Spitzer R L, Gibbon M, Williams J BW. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID). New York; New York State Psychiatric Institute, Biometrics Research 1995
• 19 Ghaemi S N, Zarate C A, Popli A P, Pillay S S, Cole J O. Is there a relationship between clozapine and obsessive-compulsive disorder. A retrospective chart review?.  Compr Psychiat. 1995;  36 267-270
• 20 Goodman W K, Price L H, Rasmussen S A, Mazure C, Fleismann R L, Hill C L, Heninger G R, Charney D S. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS), I: development, use and reliability.  Arch Gen Psychiat. 1989;  46 1006-1011
• 21 Hwang M Y, Hollander E. Schizo-obsessive disorders.  Psychiatr Ann. 1993;  23 396-401
• 22 Karno M, Golding J M, Sorenson S B, Burnbaum R A. The epidemiology of obsessive compulsive disorder in 5 U.S. communities.  Arch Gen Psych. 1988;  45 1094-1099
• 23 Kay S R, Fiszbein A, Opler L A. The positive and negative syndrome scale (PANSS) for schizophrenia.  Schizophr Bull. 1987;  13 261-276
• 24 La Porta L D. More on obsessive-compulsive symptoms and clozapine.  J Clin Psychiat. 1994;  55 312
• 25 Patel B, Tandon R. Development of obsessive-compulsive symptoms during clozapine treatment) letter).  Am J Psychiat. 1993;  150 836
• 26 Patil V J. Development of transient obsessive-compulsive symptoms during treatment with clozapine (letter).  Am J Psychiat. 1992;  149 272
• 27 Poyurovsky M, Dorfman-Etrog P, Hermesh H, Munitz H, Tollefson G D, Weizman A. Beneficial effect of olanzapine in schizophrenic patients with obsessive-compulsive symptoms.  Int Clin Psychopharmacol. 2000;  15 169-173
• 28 Poyurovsky M, Hermesh H, Weizman A. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients.  Clin Neuropharmacol. 1996;  19 305-313
• 29 Poyurovsky M, Hramenkov S, Isakov V, Rauchverger B, Modai I, Schneidman M, Fuchs C, Weizman A. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia.  Psychiatry Res. 2001;  102 49-57
• 30 Poyurovsky M, Weizman A. Beneficial effect of clozapine in schizophrenic patients with comorbid obsessive-compulsive symptoms (abstract. (Presented at the 150-th Annual Meeting of the APA. 1997 San Diego, Ca, USA, (b): 136;
• 31 Reznik I, Sirota P. Obsessive-compulsive symptoms in schizophrenia: a randomized controlled trial with SSRI’s and neuroleptics.  J Clin Psychopharmacol. 2000;  20 410-416
• 32 Reznik I, Mester R, Kotler M, Weizman A. Obsessive-compulsive schizophrenia: a new diagnostic entity.  J Neuropsychiat Clin Neurosci. 2001;  13 115-116
• 33 Robinson S, Winnik H Z, Weiss A A. ”Obsessive psychosis”: justification for a separate clinical entity.  Isr Ann Psychiatr Relat Discip. 1976;  14 39-48
• 34 Strous R D, Patel J K, Zimmet S, Green A I. Clozapine and paroxetine in the treatment of schizophrenia with obsessive-compulsive features (letter).  Am J Psychiat. 1999;  156 973-974
• 35 Taflinsky T. Obsessive-compulsive symptoms in schizophrenic patients treated with clozapine (abstract).  Eur Neuropsychopharmacol. 2000;  36 (suppl) P.2.074
• 36 Tibbo P, Gendemann K. Improvement of obsessions and compulsions with clozapine in an individual with schizophrenia (letter).  Can J Psychiatry. 1999;  44 1049-1050
• 37 Tibbo P, Warneke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap.  J Psychiatry Neurosci. 1999;  24 15-24
• 38 Voruganti L NP, Tremblay C, Awad A G. A prospective study of obsessive-compulsive symptoms during clozapine therapy. [poster NR 504]. Presented at the 154-th Annual Meeting of APA. 2001 New Orleans, La., USA;
• 39 Wetzel H, Anghelescu I, Szegedi A, Wiesner J, Weigmann H, Harter S, Hiemke C. Pharmacokinetic interactions of clozapine with selective serotonin reuptake inhibitors: differential effects of fluvoxamine and paroxetine in a prospective study.  J Clin Psychopharmacol. 1998;  18 2-9
• 40 Young C R, Bostic J Q, McDonald C L. Clozapine and refractory obsessive-compulsive disorder: a case report.  J Clin Psychopharmacol. 1994;  14 209-211
• 41 Zohar J. Is there room for a new diagnostic subtype - the schizo-obsessive subtype?.  CNS Spectrums. 1997;  2 49-50